Protalix BioTherapeutics (PLX) Institutional Ownership

$1.15
-0.03 (-2.54%)
(As of 04/26/2024 ET)

Institutional Ownership Changes (13F Filings) for Protalix BioTherapeutics (NYSE:PLX)

Current
Institutional Ownership
Percentage
16.53%
Number of
Institutional Buyers
(last 12 months)
12
Total
Institutional Inflows
(last 12 months)
$488.12K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$27.59K
Get PLX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Protalix BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

PLX Institutional Buying and Selling by Quarter

Protalix BioTherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/2/2024Bailard Inc.68,100$121K0.0%N/A0.095%
1/19/2024 Denali Advisors LLC94,700$169K0.1%-14.1%0.132%
11/15/2023GSA Capital Partners LLP496,781$825K0.1%N/A0.694%
11/13/2023Connor Clark & Lunn Investment Management Ltd.167,536$278K0.0%+45.0%0.234%
11/7/2023Barclays PLC46,511$77K0.0%+251.6%0.065%
10/27/2023 Allspring Global Investments Holdings LLC137,906$229K0.0%N/A0.193%
10/24/2023Bank of New York Mellon Corp165,680$275K0.0%+12.8%0.231%
10/13/2023SG Americas Securities LLC30,008$50K0.0%N/A0.042%
9/21/2023Barclays PLC13,230$26K0.0%+561.5%0.018%
8/11/2023Natixis132,000$264K0.0%N/A0.202%
8/4/2023American International Group Inc.27,034$54K0.0%N/A0.041%
7/31/2023Orin Green Financial LLC60,150$120K0.1%N/A0.092%
7/18/2023 Denali Advisors LLC110,200$220K0.1%N/A0.168%
5/10/2023Connor Clark & Lunn Investment Management Ltd.158,703$333K0.0%N/A0.243%
5/9/2023Aptus Capital Advisors LLC16,010$34K0.0%N/A0.024%
2/7/2023Commonwealth Equity Services LLC50,100$68K0.0%N/A0.101%
7/26/2022Capital Performance Advisors LLP25,974$28K0.0%N/A0.055%
5/9/2022Meitav Dash Investments Ltd.244,332$257K0.0%N/A0.527%
4/18/2022 Spire Wealth Management148,800$158K0.0%+18.3%0.321%
1/31/2022Commonwealth Equity Services LLC40,290$33K0.0%N/A0.088%
1/14/2022 Spire Wealth Management125,800$113K0.0%+598.9%0.276%
11/15/2021GSA Capital Partners LLP254,871$339K0.0%N/A0.559%
11/12/2021Credit Suisse AG31,974$43K0.0%-51.5%0.070%
8/18/2021Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538%
8/17/2021Walleye Capital LLC346,539$662K0.0%N/A0.764%
8/17/2021Walleye Trading LLC135,000$258K0.0%N/A0.297%
8/17/2021Bridgeway Capital Management LLC393,890$752K0.0%+30.2%0.868%
8/16/2021Morgan Stanley1,861,819$3.56M0.0%+3,723,538.0%4.102%
8/16/2021Credit Suisse AG65,925$126K0.0%+559.3%0.145%
8/13/2021Renaissance Technologies LLC30,075$57K0.0%-94.1%0.066%
8/12/2021XTX Topco Ltd17,148$33K0.0%N/A0.038%
8/11/2021Susquehanna Fundamental Investments LLC66,100$126K0.0%N/A0.146%
8/5/2021Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538%
5/19/2021Virtu Financial LLC27,744$124K0.0%N/A0.061%
5/18/2021Psagot Investment House Ltd.3,095,741$13.81M0.3%+558.3%6.821%
5/17/2021Schonfeld Strategic Advisors LLC89,278$399K0.0%N/A0.197%
5/17/2021DAFNA Capital Management LLC1,204,825$5.37M1.3%N/A2.655%
5/14/2021Laurion Capital Management LP42,813$191K0.0%N/A0.094%
5/14/2021Credit Suisse AG10,000$45K0.0%N/A0.022%
5/13/2021Renaissance Technologies LLC507,634$2.26M0.0%+3.9%1.119%
Protect Yourself While There’s Still Time … (Ad)

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.
5/10/2021Phoenix Holdings Ltd.244,113$1.09M0.0%N/A0.538%
5/7/2021D.A. Davidson & CO.130,700$583K0.0%N/A0.288%
4/30/2021Ground Swell Capital LLC14,684$65K0.2%N/A0.032%
4/28/2021DAVENPORT & Co LLC12,000$54K0.0%N/A0.026%
2/17/2021Jane Street Group LLC22,218$81K0.0%+51.5%0.067%
2/16/2021Squarepoint Ops LLC22,068$80K0.0%-50.6%0.066%
2/4/2021GSA Capital Partners LLP10,042$36K0.0%N/A0.030%
11/17/2020Jane Street Group LLC14,661$57K0.0%-89.8%0.044%
11/16/2020Squarepoint Ops LLC44,679$173K0.0%N/A0.134%
11/12/2020Arrowstreet Capital Limited Partnership45,853$177K0.0%+32.3%0.138%
11/10/2020Phoenix Holdings Ltd.204,355$751K0.0%+8.5%0.613%
8/31/2020Bridgeway Capital Management Inc.174,291$661K0.0%+94.8%0.537%
8/17/2020Jane Street Group LLC143,821$542K0.0%+185.6%0.443%
8/12/2020Bank of Montreal Can173,704$615K0.0%N/A0.535%
8/10/2020Phoenix Holdings Ltd.188,336$681K0.0%N/A0.581%
7/29/2020Psagot Investment House Ltd.470,255$1.73M0.0%+15.7%1.450%
5/15/2020Jane Street Group LLC50,352$124K0.0%+53.4%0.339%
(Data available from 1/1/2016 forward)

PLX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of PLX shares?

During the previous two years, 15 institutional investors and hedge funds held shares of Protalix BioTherapeutics. The most heavily invested institutionals were GSA Capital Partners LLP ($825K), Connor Clark & Lunn Investment Management Ltd. ($278K), Bank of New York Mellon Corp ($275K), Natixis ($264K), Meitav Dash Investments Ltd. ($257K), Allspring Global Investments Holdings LLC ($229K), and Denali Advisors LLC ($169K).Learn more on PLX's institutional investors.

What percentage of Protalix BioTherapeutics stock is owned by institutional investors?

16.53% of Protalix BioTherapeutics stock is owned by institutional investors. Learn more on PLX's institutional investor holdings.

Which institutional investors have been buying Protalix BioTherapeutics stock?

Of the 15 institutional investors that purchased Protalix BioTherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: GSA Capital Partners LLP ($496.78K), Meitav Dash Investments Ltd. ($244.33K), Connor Clark & Lunn Investment Management Ltd. ($210.70K), Allspring Global Investments Holdings LLC ($137.91K), Natixis ($132K), Denali Advisors LLC ($110.20K), and Bailard Inc. ($68.10K).

How much institutional buying is happening at Protalix BioTherapeutics?

Institutional investors have bought a total of 1,672,566 shares in the last 24 months. This purchase volume represents approximately $1.13M in transactions.

Which Protalix BioTherapeutics major shareholders have been selling company stock?

The following institutional investors have sold Protalix BioTherapeutics stock in the last 24 months: Denali Advisors LLC ($15.50K).

How much institutional selling is happening at Protalix BioTherapeutics?

Institutional investors have sold a total of 15,500 shares in the last 24 months. This volume of shares sold represents approximately $27.59K in transactions.


This page (NYSE:PLX) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners